[1]
“Early Virological Response of the First Line Combination Therapy (Pegylated Interferon I-2a and Ribavirin) in Iraqi Chronic Hepatitis C Patients and Their Psychological Adverse Effects”, GJMR, vol. 12, no. 11, pp. 35–46, Jan. 2013, Accessed: Aug. 13, 2026. [Online]. Available: https://medicalresearchjournal.org/index.php/GJMR/article/view/100087